Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

207.00 +2.21 (+1.08%)
Streaming Delayed Price Updated: 12:29 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Smartest Dividend Stocks to Buy With $3,000 Right Now ↗
It's not too late to reshape and optimize your portfolio for what could be a very different market environment than last year's. 
Via The Motley Fool
News headline image
Harvard’s CHIEF AI: The ‘Swiss Army Knife’ of Pathology Achieving 98% Accuracy in Cancer Diagnosis
In a landmark achievement for computational medicine, researchers at Harvard Medical School have developed a "generalist" artificial intelligence model that is fundamentally reshaping the landscape of... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Johnson &amp; Johnson Touts Encouraging Results For Experimental Lupus Treatment ↗
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE. 
Via Benzinga
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
Via MarketBeat
Topics Artificial Intelligence Death
News headline image
3 High-Yielding Dividend Kings to Buy in January for Safe Passive Income in 2026 and Beyond ↗
These companies pay high-yielding and steadily rising dividends. 
Via The Motley Fool
News headline image
2 Healthcare Stocks to Buy in a Bear Market ↗
They can help you weather the storm. 
Via The Motley Fool
Topics Economy
News headline image
Dividend Growers: 3 Stocks That Could Be Worth $1 Million in 36 Years. ↗
These dividends should continue growing. 
Via The Motley Fool
News headline image
Santa’s Empty Sleigh: Why the 2025 Rally Failure Signals a Rough Q1 for Wall Street
The highly anticipated "Santa Claus Rally" of 2025 has officially failed to materialize, leaving investors with a lump of coal as they ring in the new year. While the broader market enjoyed a year of... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s... 
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
Johnson & Johnson Near Year High ↗
Johnson & Johnson is nearing its 52-week high, driven by strong momentum and positive news, raising expectations for its upcoming earnings report amidst heightened sensitivity to market trends. 
Via Talk Markets
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Right Now ↗
These income stocks could be great buys to add to your portfolio. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
As 2025 draws to a close, the pharmaceutical industry stands at a historic crossroads. The year was defined by a widening chasm between the "metabolic haves"—those profiting from the global obesity... 
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
S&P 500 Eyes 7,000 Milestone: Technical Breakout Sets the Stage for a High-Stakes 2026
As the final closing bell of 2025 rings on Wall Street, the S&P 500 (SPX) stands on the precipice of history. After a year defined by a "triple-tailwind" of aggressive Federal Reserve easing, a... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Palantir Shares Retreat to $180.80 as Hawkish Fed Minutes and Institutional Rebalancing Cool Year-End Rally
Palantir Technologies (NYSE: PLTR) saw its shares slide in after-hours trading on Tuesday, December 30, 2025, as a combination of hawkish signals from the Federal Reserve and aggressive year-end... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
As the final trading days of 2025 unfold, the financial markets are witnessing a phenomenon that analysts have dubbed the "Great Rebalancing." While the S&P 500 is poised to finish the year with... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
As 2025 draws to a close, the global financial landscape is bracing for what analysts are calling an "Innovation Supercycle" in the mergers and acquisitions (M&A) market. With interest rates finally... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
In a move that has sent ripples through the biotech sector on the final trading days of the year, Hunterbrook Capital announced a significant bullish position in Achieve Life Sciences (NASDAQ:ACHV)... 
Via MarketMinute
Topics Product Recall
News headline image
The S&P 500 Seesaw: Analyzing IVV’s Year-End Turbulence After a Record-Breaking 2025
The financial markets are closing out 2025 in a state of high-octane paradox. The iShares Core S&P 500 ETF (NYSE Arca: IVV), the massive exchange-traded fund that serves as a cornerstone for millions... 
Via MarketMinute
Topics ETFs Economy Retirement
News headline image
Wall Street Stumbles at the Finish Line: S&P 500 and Nasdaq Fight to Break 3-Day Slide Amid Year-End Rebalancing
As the 2025 trading calendar winds down to its final hours, the festive atmosphere on Wall Street has been replaced by a clinical, high-stakes battle for technical support. On this Tuesday, December... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
As the sun sets on 2025, investors are increasingly pivoting toward the pharmaceutical sector, seeking a "defensive income fortress" to weather potential macroeconomic volatility in 2026. The... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ↗
Investors seeking reliable dividends will find that this trio of healthcare stocks offers an exciting combination of safety, growth, and income. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031? ↗
All three are buys, but for different reasons. 
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
As the final trading days of 2025 unfold, the festive exuberance that propelled Wall Street to the brink of historic milestones is beginning to cool. After a blistering mid-December surge that saw the... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
As the final trading days of 2025 draw to a close, the financial world finds itself standing on a high-altitude plateau that few predicted and many fear. The S&P 500 (INDEXSP: .INX) enters 2026 trading... 
Via MarketMinute
Topics Artificial Intelligence Bonds Earnings
News headline image
Blue-Chip Bull Run: Dow Jones Eyes 50,000 Milestone Amidst 2026 Technical Pivot
As the final bells of 2025 ring across the floor of the New York Stock Exchange, the Dow Jones Industrial Average (DJI) stands at a historic crossroads. After a year defined by a resilient "soft... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
As the final trading days of 2025 wind down, the global investment community has entered a period of intense reflection. This year’s market was defined by a breathtaking "tale of two halves," where... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit ↗
The company said that the drug did not achieve the “high-bar””efficacy targets in a planned interim analysis. 
Via Stocktwits
News headline image
Johnson &amp; Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss ↗
Johnson & Johnson's Phase 2b study for atopic dermatitis did not meet high-bar efficacy and was terminated early. 
Via Benzinga
News headline image
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare... 
Via PredictStreet
Topics Economy Emissions Product Recall
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.